Andrew Kasarskis was born on November 2,1972 and is an American biologist.
13 Facts About Andrew Kasarskis
1.
2.
Andrew Kasarskis is the Chief Data Officer at Sema4.
3.
Andrew Kasarskis was previously CDO and an Executive Vice President at the Mount Sinai Health System in New York City and, before that, vice chair of the Department of Genetics and Genomic Sciences and Co-director of the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai.
4.
Andrew Kasarskis completed bachelor's degrees in chemistry and biology at the University of Kentucky in 1992.
5.
Andrew Kasarskis worked for Sage Bionetworks and Pacific Biosciences before returning to academia.
6.
In 2019, Andrew Kasarskis was appointed Chief Data Officer and Executive Vice President of Mount Sinai Health System, where he leads efforts to improve clinical data infrastructure and leverage data to improve patient outcomes while accelerating research and innovation.
7.
Andrew Kasarskis is known for directing the first graduate course that allowed medical and PhD students to fully sequence and analyze their own genomes, along with co-instructors Michael Linderman, George Diaz, Ali Bashir, and Randi Zinberg.
8.
Andrew Kasarskis has said that courses like this will be critical for training teams of people capable of performing this type of analysis in a medical setting.
9.
Andrew Kasarskis chose whole genome sequencing because he expects the more limited exome sequencing will not be a relevant technological approach in the long term.
10.
Andrew Kasarskis has called for improvements to informed consent protocols in patient research based on the concept that studies involving DNA cannot fully be made anonymous.
11.
In 2019, Andrew Kasarskis joined a five-year collaborative study with Mount Sinai Health System, Sanofi, and Sema4, aimed to provide insights into the biological mechanisms of asthma using diverse data sets such as clinical data, genomics, immunological environmental, and sensor data from devices to carryout advanced network modeling of the disease.
12.
Andrew Kasarskis reported that understanding the molecular basis of clinical subtypes of asthma in the study would enable better management of asthma and could provide opportunities to discover new treatments for the disease.
13.
In 2020, the molecular pathogen surveillance program Andrew Kasarskis had established with Dr Harm van Bakel and others at the Mount Sinai Health System clearly demonstrated that SARS-CoV2, the virus causing COVID-19, was introduced to the New York Metropolitan Area not from Asia but predominately from Europe, with some contribution from other United States regions.